Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.
Veneti L, Seppälä E, Larsdatter Storm M, Valcarcel Salamanca B, Alnes Buanes E, Aasand N, Naseer U, Bragstad K, Hungnes O, Bøås H, Kvåle R, Golestani K, Feruglio S, Vold L, Nygård K, Whittaker R. Veneti L, et al. Among authors: hungnes o. PLoS One. 2021 Oct 11;16(10):e0258513. doi: 10.1371/journal.pone.0258513. eCollection 2021. PLoS One. 2021. PMID: 34634066 Free PMC article.
Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O; WHO European Region and the European Influenza Surveillance Network members of the reporting countries. Broberg E, et al. Among authors: hungnes o. Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30184. Euro Surveill. 2016. PMID: 27074657 Free article.
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O'Toole Á, Pereyaslov D; WHO European Region sequencing laboratories and GISAID EpiCoV group; WHO European Region sequencing laboratories and GISAID EpiCoV group*. Alm E, et al. Euro Surveill. 2020 Aug;25(32):2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410. Euro Surveill. 2020. PMID: 32794443 Free PMC article.
The impact of global lineage dynamics, border restrictions, and emergence of the B.1.1.7 lineage on the SARS-CoV-2 epidemic in Norway.
Osnes MN, Alfsnes K, Bråte J, Garcia I, Riis RK, Instefjord KH, Elshaug H, Vollan HS, Moen LV, Pedersen BN, Caugant DA, Stene-Johansen K, Hungnes O, Bragstad K, Brynildsrud O, Eldholm V. Osnes MN, et al. Among authors: hungnes o. Virus Evol. 2021 Sep 23;7(2):veab086. doi: 10.1093/ve/veab086. eCollection 2021. Virus Evol. 2021. PMID: 34659798 Free PMC article.
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G, Rø GØI, Tran T, Kran AB, Andersen JT, Vaage EB, Kolderup A, Vaage JT, Lund-Johansen F, Hungnes O. Tunheim G, et al. Among authors: hungnes o. Influenza Other Respir Viruses. 2022 Mar;16(2):204-212. doi: 10.1111/irv.12932. Epub 2021 Nov 9. Influenza Other Respir Viruses. 2022. PMID: 34751488 Free PMC article.
105 results